The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels
Open accessAbstract
Studies in humans and in experimental models of HIV-1 infection indicate an important role for monocyte chemoattractant protein-1 (MCP-1; also known as CC chemokine ligand 2), a potent chemoattractant and activator of mononuclear phagocytes (MP) in the pathogenesis of HIV-associated dementia (HAD). We determined the influence of genetic variation in MCP-1 on HIV-1 pathogenesis in large cohorts of HIV-1-infected adults and children. In adults, homozygosity for the MCP-1–2578G allele was associated with a 50% reduction in the risk of acquiring HIV-1. However, once HIV-1 infection was established, this same MCP-1 genotype was associated with accelerated disease progression and a 4.5-fold increased risk of HAD. We examined the molecular and cellular basis for these genotype–phenotype associations and found that the mutant MCP-1–2578G allele conferred greater transcriptional activity via differential DNA–protein interactions, enhanced protein production in vitro, increased serum MCP-1 levels, as well as MP infiltration into tissues. Thus, MCP-1 expression had a two-edged role in HIV-1 infection: it afforded partial protection from viral infection, but during infection, its proinflammatory properties and ability to up-regulate HIV-1 replication collectively may contribute to accelerated disease progression and increased risk of dementia. Our findings suggest that MCP-1 antagonists may be useful in HIV-1 infection, especially for HAD, and that HIV+ individuals possessing the MCP-1–2578G allele may benefit from early initiation of antiretroviral drugs that effectively cross the blood–brain barrier. In a broader context, the MCP-1–2578G allele may serve as a genetic determinant of outcome of other disease states in which MP-mediated tissue injury is central to disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
Koenig, S., Gendelman, H. E., Orenstein, J. M., Dal Canto, M. C., Pezeshkpour, G. H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M. A., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3016903 · Cited by 1,698
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Pathways to neuronal injury and apoptosis in HIV-associated dementia
Kaul, M., Garden, G. A., & Lipton, S. A. (2001) · Nature · doi:10.1038/35073667 · Cited by 1,210
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Infection of monocyte/macrophages by human T lymphotropic virus type III.
Ho, D. D., Rota, T. R., & Hirsch, M. S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112491 · Cited by 672
Glass, J. D., Fedor, H., Wesselingh, S. L., & McArthur, J. C. (1995) · Annals of Neurology · doi:10.1002/ana.410380510 · Cited by 662
Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C. H., Young, S. G., Rollins, B. J., & Charo, I. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5624 · Cited by 660
Conant, K., Garzino-Demo, A., Nath, A., McArthur, J. C., Halliday, W., Power, C., Gallo, R. C., & Major, E. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3117 · Cited by 577
Early viral brain invasion in iatrogenic human immunodeficiency virus infection
Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A., Mills, R. G., Wachsman, W., & Wiley, C. A. (1992) · Neurology · doi:10.1212/wnl.42.9.1736 · Cited by 557
A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 Expression
Rovin, B. H., Lu, L., & Saxena, R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0796 · Cited by 456
Self-citationImmunohistochemical identification of HTLV‐III antigen in brains of patients with AIDS
Gabuzda, D. H., Ho, D. D., de la Monte, S. M., Hirsch, M. S., Rota, T. R., & Sobel, R. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200304 · Cited by 377
Williams, K. C., Corey, S., Westmoreland, S. V., Pauley, D., Knight, H., deBakker, C., Alvarez, X., & Lackner, A. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.905 · Cited by 370
Gartner, S. (2000) · Science · doi:10.1126/science.287.5453.602 · Cited by 354
Mummidi, S., Ahuja, S. S., Gonalez, E., Anderson, S. A., Santiago, E. N., Stephan, K. T., Craig, F. E., O'Connell, P., Tryon, V., Clark, R. A., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-786 · Cited by 339
Self-citationKelder, W., McArthur, J. C., Nance‐Sproson, T., McClernon, D., & Griffin, D. E. (1998) · Annals of Neurology · doi:10.1002/ana.410440521 · Cited by 338
Monocyte Chemoattractant Protein-1
Gu, L., Tseng, S. C., & Rollins, B. J. (1999) · Chemical Immunology and Allergy · doi:10.1159/000058723 · Cited by 326
Szalai, C., Duba, J., Prohászka, Z., Kalina, Á., Szabó, T., Nagy, B., Horváth, L., & Császár, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00423-3 · Cited by 317
Saji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., & Toi, M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k · Cited by 288
Persidsky, Y., Ghorpade, A., Rasmussen, J., Limoges, J., Liu, X. J., Stins, M., Fiala, M., Way, D., Kim, K. S., Witte, M. H., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65476-4 · Cited by 284
Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
Xia, M., & Hyman, B. T. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029743 · Cited by 269
Weiss, J. M., Nath, A., Major, E. O., & Berman, J. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2953 · Cited by 265
O'Brien, S. J., & Moore, J. P. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17710.x · Cited by 254
Cinque, P., Vago, L., Mengozzi, M., Torri, V., Ceresa, D., Vicenzi, E., Transidico, P., Vagani, A., Sozzani, S., Mantovani, A., et al. (1998) · AIDS · doi:10.1097/00002030-199811000-00014 · Cited by 253
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
Gonzalez, E., Bamshad, M., Sato, N., Mummidi, S., Dhanda, R., Catano, G., Cabrera, S., McBride, M., Cao, X.-H., Merrill, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12004 · Cited by 253
Self-citationEpidemiology of human immunodeficiency virus encephalopathy in the United States
Janssen, R. S., Nwanyanwu, O. C., Selik, R. M., & Stehr-Green, J. K. (1992) · Neurology · doi:10.1212/wnl.42.8.1472 · Cited by 242
Huang, D., Han, Y., Rani, M. R. S., Glabinski, A., Trebst, C., Sørensen, T., Tani, M., Wang, J., Chien, P., O'Bryan, S., et al. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17709.x · Cited by 233
BELL, M. D., TAUB, D. D., & PERRY, V. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00083-8 · Cited by 177
Hirsch, V. M., Sharkey, M. E., Brown, C. R., Brichacek, B., Goldstein, S., Wakefield, J., Byrum, R., Elkins, W. R., Hahn, B. H., Lifson, J. D., et al. (1998) · Nature Medicine · doi:10.1038/3992 · Cited by 173
Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA
Mummidi, S., Bamshad, M., Ahuja, S. S., Gonzalez, E., Feuillet, P. M., Begum, K., Galvis, M. C., Kostecki, V., Valente, A. J., Murthy, K. K., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000169200 · Cited by 169
Self-citationZink, M. C., Coleman, G. D., Mankowski, J. L., Adams, R. J., Tarwater, P. M., Fox, K., & Clements, J. E. (2001) · The Journal of Infectious Diseases · doi:10.1086/323478 · Cited by 156
Lee, B., Doranz, B. J., Rana, S., Yi, Y., Mellado, M., Rodríguez-Frade, J. M., Martínez‐A, C., O’Brien, S. J., Dean, M. C., Collman, R. G., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7450-7458.1998 · Cited by 156
Price, R. W., Yiannoutsos, C. T., Clifford, D. B., Zaborski, L. B., Tselis, A. C., Sidtis, J. J., Cohen, B. A., Hall, C. D., Erice, A., & Henry, K. (1999) · AIDS · doi:10.1097/00002030-199909100-00011 · Cited by 139
Peters, W., & Charo, I. F. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00011 · Cited by 122
Mechanisms of leukocyte trafficking into the CNS.
Wu, D. T., Woodman, S. E., Weiss, J. M., McManus, C. M., D’Aversa, T. G., Hesselgesser, J., Major, E. O., Nath, A., & Berman, J. W. (2000) · PubMed · Cited by 119
The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.
Rodríguez-Frade, J. M., Llorente, M., Mellado, M., Alcamí, J., Gutierrez-Ramos, J.-C., Zaballos, Á., del Real, G., & Martínez‐A, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119558 · Cited by 111
Bernasconi, S., Cinque, P. M., Peri, G., Sozzani, S., Crociati, A., Torri, V., Vicenzi, E., Vago, L., Lazzarin, A., Poli, G., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1098 · Cited by 98
Cotter, R. L., Burke, W. J., Thomas, V. S., POTTER, J. F., Zheng, J., & Gendelman, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.416 · Cited by 91
Mangano, A. M., Gonzalez, E., Dhanda, R., Catano, G., Bamshad, M., Bock, A., Duggirala, R., Williams, K., Mummidi, S., Clark, R. A., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/320705 · Cited by 86
Self-citationVicenzi, E., Alfano, M., Ghezzi, S., Gatti, A., Veglia, F., Lazzarin, A., Sozzani, S., Mantovani, A., & Poli, G. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.3.405 · Cited by 80
The neuropathogenesis of HIV-1 infection
Zink, W. E., Zheng, J., Persidsky, Y., Poluektova, L. Y., & Gendelman, H. E. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(99)00152-2 · Cited by 78
Weiss, L., Si‐Mohamed, A., Giral, P., Castiel, P., Ledur, A., Blondin, C., Kazatchkine, M. D., & Haeffner‐Cavaillon, N. (1997) · The Journal of Infectious Diseases · doi:10.1086/517341 · Cited by 78
Cited by
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Neurological complications of HIV infection
McArthur, J. C., Brew, B. J., & Nath, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70165-4 · Cited by 554
Ancuta, P., Kamat, A., Kunstman, K. J., Kim, E.-Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002516 · Cited by 499
“We found an association between HAD and increased plasma sCD14 and CCL2, which are soluble markers of Mo activation [58,60,61].”
Background
Metadata
- Authors
- Gonzalez, E., Rovin, B. H., Sen, L., Cooke, G., Dhanda, R., Mummidi, S., Kulkarni, H., Bamshad, M. J., Telles, V., Anderson, S. A., Walter, E. A., Stephan, K. T., Deucher, M., Mangano, A., Bologna, R., Ahuja, S. S., Dolan, M. J., & Ahuja, S. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-10-08
- Volume
- 99
- Issue
- 21
- Pages
- 13795-13800
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2026924553
- Cited by
- 302
- References
- 42
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.